Cytiva, a Danaher company and leader in the life sciences industry, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined forces to expand analytical capabilities for protein research.

Cytiva是一家隶属于丹纳赫集团的生命科学领域领军企业，与专注于分子分析的丹麦公司Fida Biosystems携手合作，共同拓展蛋白质研究的分析能力。

The collaboration combines Cytiva’s Biacore surface plasmon resonance (SPR) systems with Fidabio’s in-solution Flow-Induced Dispersion Analysis (FIDA) technology, providing both a complementary and an orthogonal approach that gives scientists a more complete picture of molecular interactions. By linking structural details—such as protein size and stability—with precise binding and interaction data, researchers can make faster, more confident decisions earlier in development..

此次合作将Cytiva的Biacore表面等离子体共振（SPR）系统与Fidabio的溶液中流动诱导色散分析（FIDA）技术相结合，提供了一种互补且正交的方法，使科学家能够更全面地了解分子相互作用。通过将蛋白质大小和稳定性等结构细节与精确的结合和相互作用数据相结合，研究人员可以在开发的早期阶段更快、更有信心地做出决策。

Why it matters:

为什么这很重要：

Brian Sørensen, CEO, Fida Biosystems, says

Fida Biosystems首席执行官布莱恩·索伦森表示

: “Combining technologies with Cytiva fosters deeper insight, giving researchers greater confidence in their results. This collaboration supports our mission to advance biophysical analysis and empower scientists with faster, more informative data for complex molecular research.”

“将技术与Cytiva相结合能够带来更深入的见解，使研究人员对他们的结果更具信心。此次合作支持了我们推进生物物理分析的使命，并为科学家提供更快、信息更丰富的数据，助力复杂分子研究。”

Tim Bervoets, President, Discovery & Medical, Cytiva, says

Cytiva 发现与医学部门总裁 Tim Bervoets 表示

: “Researchers need to understand how their molecules behave, and they need that insight quickly. Pairing Biacore SPR with FIDA measurements gives them a more complete picture, without adding complexity. It’s a practical step forward that supports confident decisions and keeps workflows moving. In essence, it helps accelerate the researcher’s time to insight.”.

“研究人员需要了解他们的分子行为，并且需要快速获得这些见解。将Biacore SPR与FIDA测量相结合，为他们提供了更完整的图像，而不会增加复杂性。这是一个切实的进步，支持研究人员做出自信的决策并保持工作流程的顺畅。简而言之，它有助于加速研究人员获得见解的时间。”

Fidabio’s technology provides both complimentary and orthogonal data to the Biacore SPR system’s data, providing critical information on the quality of sample. By combining two methods, researchers can link structural information, such as protein size and stability, with detailed binding and interaction data.

Fidabio的技术为Biacore SPR系统的数据提供了互补和正交的数据，提供了关于样品质量的关键信息。通过结合两种方法，研究人员可以将蛋白质大小和稳定性等结构信息与详细的结合和相互作用数据联系起来。

This combined view helps accelerate research on complex molecules, including bispecific antibodies and degraders, while also improving confidence in experimental results..

这种综合视图有助于加速对复杂分子（包括双特异性抗体和降解剂）的研究，同时提高对实验结果的信心。

This partnership reflects Cytiva’s and Danaher’s shared mission to advance analytical science, enable confident, data-driven discoveries, and improve lives through innovation.

这种合作关系反映了Cytiva和Danaher共同的使命，即推动分析科学的发展，实现自信、数据驱动的发现，并通过创新改善生活。

Cytiva, the drop logo, and Biacore are trademarks of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva.

Cytiva、水滴形标志和Biacore是Global Life Sciences Solutions USA LLC或其以Cytiva名义开展业务的关联公司的商标。

FIDA and Fidabio are registered trademarks of Fida Biosystems A/S.

FIDA 和 Fidabio 是 Fida Biosystems A/S 的注册商标。

About Fida Biosystems

关于菲达生物系统

Fidabio is a leading innovator in biophysical analysis, delivering in-solution biophysical technology that advances research productivity. Its FIDA platform supports the new wave of drug modalities and targets and enables high double-digit increase of through-put on of established workflows accelerating progress from discovery through development, and opening the space of in-lab creativity thanks to native, crude-sample assays..

Fidabio是生物物理分析领域的领先创新者，提供提升研究效率的溶液内生物物理技术。其FIDA平台支持新一代药物模式和靶点，并能将现有工作流程的通量提高数十个百分点，从而加速从发现到开发的进展，同时通过天然、粗样品检测开辟实验室创意空间。

Media contact

媒体联系人

Brian Sørensen

布莱恩·索伦森

brian@fidabio.com

布赖恩@fidabio.com

About Cytiva

关于Cytiva

At Cytiva, a Danaher company, our mission is to advance and accelerate the development of therapeutics. With 15 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers.

在Cytiva，一家丹纳赫公司，我们的使命是推动和加速治疗药物的开发。我们在40多个国家拥有15,000名员工，致力于运用我们的专业知识和才能，为客户提供更高的灵活性、产能和效率。我们广泛而深入的工具与技术组合、全球规模以及一流的服务，为从发现到交付的各个环节提供了关键支持，客户涵盖研究人员、新兴生物技术公司、大规模生物制药企业以及合同制造商。

Learn more at cytiva.com.

请访问 cytiva.com 了解更多信息。

Media contact

媒体联系人

James McGarry

詹姆斯·麦加里

James.Mcgarry@cytiva.com

詹姆斯.麦加里@思拓凡.com

Source: cytivalifesciences.com

来源：cytivalifesciences.com